Search research articles
Contact Us
Filters
Showing results (31-40 of 99) with videos related to
Page
of 10
Sort By:
Journal of Pharmaceutical Sciences
|
November 7, 2020
Transient, Tunable Expression of NTCP and BSEP in MDCKII Cells for Kinetic Delineation of the Rate-Determining Process and Inhibitory Effects of Rifampicin in Hepatobiliary Transport of Taurocholate
Sumito Ito, Wooin Lee, Ji Eun Park, et al.
Journal of Pharmaceutical Sciences
|
October 15, 2020
Improved Prediction of the Drug-Drug Interactions of Pemafibrate Caused by Cyclosporine A and Rifampicin via PBPK Modeling: Consideration of the Albumin-Mediated Hepatic Uptake of Pemafibrate and Inhibition Constants With Preincubation Against OATP1B
Ji Eun Park, Yoshihisa Shitara, Wooin Lee, et al.
Scientific Reports
|
March 13, 2019
H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth
Min Jae Lee, Zachary Miller, Ji Eun Park, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 18, 2019
Expanded Physiologically-Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction
Ryuta Asaumi, Karsten Menzel, Wooin Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 28, 2015
Polymer micelle formulations of proteasome inhibitor carfilzomib for improved metabolic stability and anticancer efficacy in human multiple myeloma and lung cancer cell lines
Lin Ao, Derek Reichel, Di Hu, et al.
Biomaterials
|
July 27, 2018
Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors
Hyesun Hyun, Joonyoung Park, Kiela Willis, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
March 24, 2018
A Comparative In Vivo Study of Albumin-Coated Paclitaxel Nanocrystals and Abraxane
Joonyoung Park, Ji Eun Park, Victoria E Hedrick, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 26, 2018
Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug-Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects
Ryuta Asaumi, Kota Toshimoto, Yoshifusa Tobe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 25, 2018
Physiologically Based Pharmacokinetic Modeling of Bosentan Identifies the Saturable Hepatic Uptake As a Major Contributor to Its Nonlinear Pharmacokinetics
Masanobu Sato, Kota Toshimoto, Atsuko Tomaru, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
August 16, 2015
The identification of lobeglitazone metabolites in rat liver microsomes and the kinetics of the in vivo formation of the major metabolite M1 in rats
Jong-Hwa Lee, Sung Hoon Ahn, Han-Joo Maeng, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 99) with videos related to
Sort By:
Page
of 10
Journal of Pharmaceutical Sciences
|
November 7, 2020
Transient, Tunable Expression of NTCP and BSEP in MDCKII Cells for Kinetic Delineation of the Rate-Determining Process and Inhibitory Effects of Rifampicin in Hepatobiliary Transport of Taurocholate
Sumito Ito, Wooin Lee, Ji Eun Park, et al.
Journal of Pharmaceutical Sciences
|
October 15, 2020
Improved Prediction of the Drug-Drug Interactions of Pemafibrate Caused by Cyclosporine A and Rifampicin via PBPK Modeling: Consideration of the Albumin-Mediated Hepatic Uptake of Pemafibrate and Inhibition Constants With Preincubation Against OATP1B
Ji Eun Park, Yoshihisa Shitara, Wooin Lee, et al.
Scientific Reports
|
March 13, 2019
H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth
Min Jae Lee, Zachary Miller, Ji Eun Park, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 18, 2019
Expanded Physiologically-Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction
Ryuta Asaumi, Karsten Menzel, Wooin Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 28, 2015
Polymer micelle formulations of proteasome inhibitor carfilzomib for improved metabolic stability and anticancer efficacy in human multiple myeloma and lung cancer cell lines
Lin Ao, Derek Reichel, Di Hu, et al.
Biomaterials
|
July 27, 2018
Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors
Hyesun Hyun, Joonyoung Park, Kiela Willis, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
March 24, 2018
A Comparative In Vivo Study of Albumin-Coated Paclitaxel Nanocrystals and Abraxane
Joonyoung Park, Ji Eun Park, Victoria E Hedrick, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 26, 2018
Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug-Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects
Ryuta Asaumi, Kota Toshimoto, Yoshifusa Tobe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 25, 2018
Physiologically Based Pharmacokinetic Modeling of Bosentan Identifies the Saturable Hepatic Uptake As a Major Contributor to Its Nonlinear Pharmacokinetics
Masanobu Sato, Kota Toshimoto, Atsuko Tomaru, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
August 16, 2015
The identification of lobeglitazone metabolites in rat liver microsomes and the kinetics of the in vivo formation of the major metabolite M1 in rats
Jong-Hwa Lee, Sung Hoon Ahn, Han-Joo Maeng, et al.
Page
of 10